Cover Image for BIO 2025 - Precision in practice: Australia's world-leading precision oncology platforms
Cover Image for BIO 2025 - Precision in practice: Australia's world-leading precision oncology platforms

BIO 2025 - Precision in practice: Australia's world-leading precision oncology platforms

Hosted by Michelle Havill, Shaun McAlpine & Daniel Meninelli
Registration
Approval Required
Your registration is subject to approval by the host.
Welcome! To join the event, please register below.
About Event

NSW Government invites you to a breakfast panel to discover and connect with Australia's trio of world-leading precision oncology initiatives:

ZERO Childhood Cancer - World leading comprehensive national precision medicine program for all children with cancer in Australia (presenter: Associate Professor Vanessa Tyrrell).

PrOSPeCT - a landmark precision oncology initiative, and the largest cancer genomics initiative in Australia (presenter: Professor David Thomas).

ProCan® - a unique platform that uses proteomic insights to enhance the outcomes of oncology research and clinical trials globally (Professor Roger Reddel).

Enabled by one of the world’s top ranked healthcare systems, generous R&D tax incentives, and a genetically diverse and willing patient population – NSW, Australia, is a preferred destination for global biopharma to accelerate innovation in oncology.

Location
The Westin Boston Seaport District
425 Summer St, Boston, MA 02210, USA